RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.320
+0.005 (0.38%)
At close: Aug 20, 2026, 4:00 PM EDT
1.320
0.00 (0.00%)
After-hours: Aug 20, 2026, 4:10 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $59.57 million as of August 20, 2026. Its market cap has increased by 76.43% in one year.
Market Cap
59.57M
Enterprise Value
50.48M
1-Year Change
76.43%
Ranking
Category
Stock Price
$1.32
ChartMarket Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $59.57M, a decrease of -13.22%. That is a compound annual growth rate of -2.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 59.57M | 93.48% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 65.06M |
| OS Therapies | 65.03M |
| ImageneBio | 64.59M |
| Xilio Therapeutics | 61.92M |
| INmune Bio | 61.89M |
| Heron Therapeutics | 59.78M |
| BioStem Technologies | 59.71M |
| eXoZymes | 58.31M |